Cardiff Oncology, Inc.CRDFNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P74
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -6.92% |
| Q3 2025 | -17.19% |
| Q2 2025 | -17.31% |
| Q1 2025 | -38.80% |
| Q4 2024 | 65.17% |
| Q3 2024 | -9.82% |
| Q2 2024 | -14.25% |
| Q1 2024 | -12.68% |
| Q4 2023 | -10.39% |
| Q3 2023 | -10.11% |
| Q2 2023 | -10.28% |
| Q1 2023 | -9.25% |
| Q4 2022 | -8.89% |
| Q3 2022 | -6.09% |
| Q2 2022 | -7.56% |
| Q1 2022 | -13.00% |
| Q4 2021 | 2.45% |
| Q3 2021 | -5.79% |
| Q2 2021 | 6.71% |
| Q1 2021 | -38.83% |
| Q4 2020 | 282.30% |
| Q3 2020 | -14.64% |
| Q2 2020 | 171.42% |
| Q1 2020 | -29.38% |
| Q4 2019 | -20.54% |
| Q3 2019 | -32.47% |
| Q2 2019 | -30.97% |
| Q1 2019 | -10.02% |
| Q4 2018 | -35.32% |
| Q3 2018 | -71.17% |
| Q2 2018 | 132.14% |
| Q1 2018 | -47.94% |
| Q4 2017 | 50.05% |
| Q3 2017 | -4.57% |
| Q2 2017 | -67.14% |
| Q1 2017 | -46.53% |
| Q4 2016 | -27.73% |
| Q3 2016 | -17.90% |
| Q2 2016 | -21.40% |
| Q1 2016 | -15.58% |